The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 137

More JCP Articles

JCP
Article

October 26, 2016

Bipolar disorder is often comorbid with other diagnoses including conduct disorder and ADHD. Are youth with bipolar disorder also at risk for initiating smoking and substance use? This study…
, , , et al
JCP
Commentary

October 26, 2016

This commentary discusses the article "Are Posttraumatic Stress Symptoms Related to Mental Health Service Use? A Prospective Study of Danish Soldiers Deployed to Afghanistan" by Madsen et al.
, ,
JCP
Original Research

October 26, 2016

Pharmacotherapy is widely available for patients with MDD, but as many as 40% have a delayed response or fail to respond to treatment. In this RCT, see how the…
, , , et al
JCP
Original Research

October 26, 2016

Since 2008, significant changes in federal policies have been designed to increase access to mental health treatment. Have these changes been effective in influencing treatment-seeking patterns? Han and colleagues…
, , , et al
JCP
Educational Activity

October 26, 2016

JCP
Original Research

October 25, 2016

The “C” word is frightening to patients with serious mental illness as much as to anyone, but whether these patients’ survival is equal to those without an SMI is…
, , , et al
JCP
Supplement Article

September 30, 2016

Read the recommendations of experts on the use of long-acting injectable antipsychotic medications in patients with schizophrenia.
, , , et al
JCP
Original Research

September 28, 2016

SSRIs, as well as depression itself, have been associated with an increased risk of type 2 diabetes. To discover more about this link, Noordam et al looked at the…
, , , et al
JCP
Letter to the Editor

September 28, 2016

JCP
Letter to the Editor

September 28, 2016

JCP
Original Research

September 28, 2016

What can you do when chronic pain is a problem for your trauma patients for whom opioids may lead to a substance use disorder? This study investigates whether buprenorphine,…
, , , et al
JCP
Clinical and Practical Psychopharmacology

September 28, 2016

Patients with schizophrenia have increased rates of many cardiometabolic risk factors. Chittaranjan Andrade, MD, takes a look at the impact of pharmacological interventions, such as metformin, topiramate, and aripiprazole,…

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe